$171.98

1.45 (0.85%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

COH General Information

Cochlear Limited
COH
http://www.cochlear.com
Health Care Equipment
9,842
58

COH Current Share Price+

Current Price $171.980
Open $168.900
High $172.950
Low $168.730
Last Close $170.530
Volume 43447
Price Movement $1.45 ( 0.85% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

COH Research

COH Recommendation

Current recommendation UNLOCK
12 month range UNLOCK
Maximum portfolio weighting UNLOCK
Business risk UNLOCK
Share price risk UNLOCK

COH Company Overview

Business Description

Cochlear Limited (COH) is a manufacturer and distributor of cochlear implantable devices for hearing impaired. Cochlear have operations in more than 20 countries distributing its products in America, Asia Pacific, Europe, Middle East and Africa. It offers three main products namely: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.

COH Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 296.61 516.50 16.20% 33.02 361.55 2.12% 100.0%
2019 F 255.32 444.61 4.20% 38.36 311.22 1.83% 100.0%
2018 A 245.85 426.80 9.70% 40.79 300.00 1.72% 100.0%

COH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Cochlear (COH) $9,921M 0.0828 0.1186 0.1376 40.7980 36.4715 32.0601 1.75% 1.89% 2.16%
Fisher & Paykel Hlth (FPH) $6,695M 0.1095 0.0367 0.1421 34.8241 33.5922 29.4132 1.71% 2.09% 2.40%
ResMed (RMD) $22,714M 0.2815 0.1292 0.1227 36.3263 32.1695 28.6536 1.21% 1.60% 1.78%

COH Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.23 38.40 16.10 3.00
Market 0.91 15.60 1.47 1.56
Sector 0.94 15.50 1.67 2.50

COH Directors

Name Position Start Date
Ms Catriona Alison Deans Non-Executive Director 1 Jan 2015
Mr Andrew Leslie Denver Non-Executive Director 1 Feb 2007
Ms Yasmin Anita Allen Non-Executive Director 2 Aug 2010
Mr Donal Paul O'Dwyer Non-Executive Director 1 Aug 2005
Mr Glen Francis Boreham Non-Executive Director 1 Jan 2015
Professor Bruce Gregory Robinson Non-Executive Director 13 Dec 2016
Mr Shah Abbas Hussain Non-Executive Director 20 Nov 2018
Mr Roderic (Rick) Holliday-Smith Non-Executive Director, Non-Executive Chairman 1 Mar 2005
Mr Dig Howitt President, Chief Executive Officer, Managing Director 14 Nov 2017

COH Management

Name Position
Brent Cubis Chief Financial Officer
David Hackshall Chief Information Officer
David Cade Chief Medical Officer
Jan Janssen Chief Technology Officer
Ray Jarman Company Secretary
Rom Mendel President, Acoustics
Tony Manna President, Americas Region
Anthony Bishop President, Asia Pacific Region
Richard Brook President, EMEA & Latin American Region
Stu Sayers President, Services
Dean Phizacklea Senior Vice President, Global Marketing
Jennifer Hornery Senior Vice President, People & Culture
Greg Bodkin Senior Vice President, Supply Chain & Operational Excellence

COH Substantial Shareholders

Holding Name
4,532,973 (7.90%) Baillie Gifford & Co
3,457,684 (6%) BlackRock Group

COH Calendar of Events

Date Event
13 August 2019 Report (Annual)
13 August 2019 Report (Prelim)
12 February 2019 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.